{"database":"biostudies-literature","file_versions":[],"scores":null,"additional":{"omics_type":["Unknown"],"volume":["14(1)"],"submitter":["Lin CH"],"pubmed_abstract":["Herein, we report a case of bilateral simultaneous central retinal vein occlusion (CRVO) secondary to coronavirus disease 2019 (COVID-19). A 48-year-old man, with hypertension, type 2 diabetes mellitus, and stage 4 chronic kidney disease, diagnosed with COVID-19 1 month ago presented to the ophthalmology department with blurred vision in both eyes for 2 weeks. Ocular examination revealed a classic clinical presentation of CRVO in both eyes. Optical coherence tomography revealed increased central macular thickness with intraretinal and subretinal fluid in both eyes. Laboratory data revealed elevated D-dimer and C-reactive protein (CRP) levels. The levels of other hypercoagulability markers were normal. The patient received intravitreal anti-vascular endothelial growth factor therapy in both"],"journal":["Case reports in ophthalmology"],"pagination":["56-61"],"full_dataset_link":["https://www.ebi.ac.uk/biostudies/studies/S-EPMC9938397"],"repository":["biostudies-literature"],"pubmed_title":["Bilateral Simultaneous Central Retinal Vein Occlusion Secondary to COVID-19: A Case Report."],"pmcid":["PMC9938397"],"pubmed_authors":["Sun IT","Lin CH"],"additional_accession":[]},"is_claimable":false,"name":"Bilateral Simultaneous Central Retinal Vein Occlusion Secondary to COVID-19: A Case Report.","description":"Herein, we report a case of bilateral simultaneous central retinal vein occlusion (CRVO) secondary to coronavirus disease 2019 (COVID-19). A 48-year-old man, with hypertension, type 2 diabetes mellitus, and stage 4 chronic kidney disease, diagnosed with COVID-19 1 month ago presented to the ophthalmology department with blurred vision in both eyes for 2 weeks. Ocular examination revealed a classic clinical presentation of CRVO in both eyes. Optical coherence tomography revealed increased central macular thickness with intraretinal and subretinal fluid in both eyes. Laboratory data revealed elevated D-dimer and C-reactive protein (CRP) levels. The levels of other hypercoagulability markers were normal. The patient received intravitreal anti-vascular endothelial growth factor therapy in both","dates":{"release":"2023-01-01T00:00:00Z","publication":"2023 Jan-Dec","modification":"2025-04-21T15:13:39.342Z","creation":"2025-04-21T15:13:39.342Z"},"accession":"S-EPMC9938397","cross_references":{"pubmed":["36820307"],"doi":["10.1159/000529298"]}}